Processa Pharmaceuticals, Inc. Stock
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
06:00:00 20/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 2.150 USD | +2.38% |
|
-16.02% | -25.35% |
| Market Cap | 5.78M 4.95M 4.63M 4.24M 7.98M 552M 8.11M 54.59M 21.37M 277M 21.69M 21.21M 915M | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 238K 205K 191K 175K 329K 22.79M 335K 2.25M 882K 11.43M 895K 876K 37.79M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | +2.38% | ||
| 1 week | -16.02% | ||
| 1 month | -3.15% | ||
| 3 months | -17.62% | ||
| 6 months | -5.70% | ||
| Current year | -25.35% |
| 1 week | 2.04 |  | 2.59 |
| 1 month | 1.8 | | 3.11 |
| Current year | 1.67 | | 3.8 |
| 1 year | 1.67 | | 14.24 |
| 3 years | 1.67 | | 450 |
| 5 years | 1.67 | | 4,495.35 |
| 10 years | 1.67 | | 125,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 08/08/2023 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 29/03/2011 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 04/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 29/03/2011 |
Justin Yorke
CHM | Chairman | 60 | 16/08/2022 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 13/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/8/26 | Fiscal year | Chief Executive Officer | 3,200 | 0.1156% | ||
| 26/7/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 26/7/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.38% | -16.02% | -58.35% | -98.77% | 5.78M | |
| -1.90% | +2.37% | +69.11% | +110.88% | 73.45B | |
| +0.87% | +17.17% | +53.05% | +95.59% | 62.99B | |
| +1.71% | -1.22% | +2.71% | +493.91% | 28.05B | |
| -1.40% | +4.18% | +54.52% | +19.60% | 25.42B | |
| +21.96% | +21.98% | +1.54% | -3.75% | 23.3B | |
| +2.28% | +7.98% | +42.75% | -12.34% | 19.45B | |
| 0.00% | -4.11% | +243.99% | +423.83% | 18.16B | |
| -3.50% | -0.95% | +17.17% | +534.55% | 16.53B | |
| +2.39% | +7.96% | +44.96% | +154.52% | 13.16B | |
| Average | +2.52% | +0.45% | +47.15% | +171.80% | 28.05B | |
| Weighted average by Cap. | +1.66% | +4.39% | +57.23% | +166.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -11.85M -10.17M -9.49M -8.71M -16.38M -1.13B -16.65M -112M -43.86M -568M -44.49M -43.53M -1.88B | -13.56M -11.64M -10.86M -9.97M -18.74M -1.3B -19.05M -128M -50.2M -650M -50.93M -49.82M -2.15B |
| Net Debt | -1.12M -959K -895K -821K -1.54M -107M -1.57M -10.57M -4.14M -53.59M -4.2M -4.11M -177M | -5.54M -4.75M -4.44M -4.07M -7.65M -529M -7.78M -52.33M -20.49M -265M -20.79M -20.34M -878M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | USD 2.150 | +2.38% | 25,071 |
| 18/08/26 | USD 2.100 | -1.41% | 51,877 |
| 17/08/26 | USD 2.130 | -12.35% | 61,305 |
| 14/08/26 | USD 2.430 | -2.80% | 50,194 |
| 13/08/26 | USD 2.500 | -2.34% | 38,451 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
